Seynapsis Pharma Private Limited - Company Profile

It is a paper private limited company based in Pune City, Maharashtra, India, established in 2025.
2025 Pune City, Maharashtra, India Active
Last Updated:
Access Report
About Seynapsis Pharma Private Limited

Seynapsis Pharma Private Limited, a active private limited company, was established on 21 February 2025 in Pune City, Maharashtra, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21002PN2025PTC238417. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Manoj Ghanshyamdas Bhutada (Director), Navalkishor Bansilal Lakhotia (Director), Amit Maniklal Wadhwani (Director). Past directors included Mukesh Narayandas Harajakar. It is based at Aakash Ganga, Bldg.-D,, Flat No. -105, Rahatani, Pune City, Maharashtra, 411017.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21002PN2025PTC238417

  • Registration Number

    238417

  • Incorporation Date

    21 February 2025

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Months 21 Days
Company report

Seynapsis Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Seynapsis Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Seynapsis Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Manoj Ghanshyamdas Bhutada Director 21 Feb 2025 Current
Navalkishor Bansilal Lakhotia Director 21 Feb 2025 Current
Amit Maniklal Wadhwani Director 21 Feb 2025 Current
Mukesh Narayandas Harajakar Director 05 Dec 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Dec 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Seynapsis Pharma.
Seynapsis Pharma revenue growth over time
Seynapsis Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Seynapsis Pharma?

Unlock access to Seynapsis Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Seynapsis Pharma?

Unlock and access historical data on people associated with Seynapsis Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Seynapsis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seynapsis Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Seynapsis Pharma
Recent Activity within the Organization
  • Director Appointment

    Mukesh Narayandas Harajakar was appointed as a Director was appointed as a Director on 05 Dec 2025 & has been associated with this company since 2 months 9 days . was recorded as a recent event.

  • Director Appointment

    Manoj Ghanshyamdas Bhutada was appointed as a Director was appointed as a Director on 21 Feb 2025 & has been associated with this company since 11 months 21 days . was recorded as a recent event.

  • Director Appointment

    Navalkishor Bansilal Lakhotia was appointed as a Director was appointed as a Director on 21 Feb 2025 & has been associated with this company since 11 months 21 days . was recorded as a recent event.

  • Director Appointment

    Progress on Amit Maniklal Wadhwani was appointed as a Director was appointed as a Director on 21 Feb 2025 & has been associated with this company since 11 months 21 days . was documented.

  • Company Incorporation

    Progress on Seynapsis Pharma Private Limited was registered on 21 Feb 2025 with Roc Pune & aged 11 months 21 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Seynapsis Pharma Private Limited?

The CIN of Seynapsis Pharma Private Limited is U21002PN2025PTC238417.

Where is Seynapsis Pharma Private Limited headquartered?

Seynapsis Pharma Private Limited is headquartered at Aakash Ganga, Bldg.-D,, Flat No. -105, Rahatani, Pune City, Maharashtra, 411017.

When was Seynapsis Pharma Private Limited incorporated?

Seynapsis Pharma Private Limited was incorporated on 21 February 2025.

Who are the current directors of Seynapsis Pharma Private Limited?

The current directors of Seynapsis Pharma Private Limited are

What is the primary industry of Seynapsis Pharma Private Limited?

The primary industry of Seynapsis Pharma Private Limited is Paper.

Is Seynapsis Pharma Private Limited a listed company?

Seynapsis Pharma Private Limited is unlisted.

What is the capital structure of Seynapsis Pharma Private Limited?

The authorized capital of Seynapsis Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available